Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in Nove...
Motus GI reported revenue of $0 for fiscal year 2023, and net income of -$12.87 million. In Q1 2024 (the quarter ended March 31, 2024) revenue was $0. Its market capitalization was $1,277 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of October 9, 2026.
No profile data available.